期刊
CHEMICAL SCIENCE
卷 9, 期 23, 页码 5278-5283出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8sc01735b
关键词
-
资金
- Scripps Research Institute (TSRI)
- Pfizer, Inc.
- Bristol-Myers Squibb
- National Institutes of Health [1R35GM125052]
- NSF [NSF/DGE-1346837, NSF/DBI-1359160]
A nickel-catalyzed conjunctive cross-coupling of non-conjugated alkenes, alkyl halides, and alkylzinc reagents is reported. Regioselectivity is controlled by chelation of a removable bidentate 8-aminoquinoline directing group. Under optimized conditions, a wide range of 1,2-dialkylated products can be accessed in moderate to excellent yields. To the best of our knowledge, this report represents the first example of three-component 1,2-dialkylation of non-conjugated alkenes to introduce differentiated alkyl fragments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据